EMA Expired: Avandia (rosiglitazone) — SmithKline Beecham Plc

View source ↗

Summary

Expired European marketing authorization for Avandia (rosiglitazone) by SmithKline Beecham Plc, for type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Avandia (rosiglitazone)

Snippet

Status: Expired. Therapeutic area: Diabetes Mellitus, Type 2. MAH: SmithKline Beecham Plc. Decision date: 03/12/2010